查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405828

過敏診斷和治療藥物市場規模、佔有率、趨勢分析報告：按類型、過敏原類型、測試類型、地區、細分市場預測，2024-2030

Allergy Diagnostics And Therapeutics Market Size, Share & Trends Analysis Report By Type (Diagnostics, Therapeutics), By Allergen Type (Food, Inhaled, Drug), By Test Type, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

過敏診斷和治療藥物市場的成長和趨勢：

根據Grand View Research, Inc.的最新報告，預計2023年全球過敏診斷和治療藥物市場價值為583.1億美元，預計2024年至2030年複合年成長率為8.7%。 。

過敏性疾病的盛行率不斷上升，加上對先進療法的需求，預計將在未來幾年推動市場成長。根據美國過敏、氣喘和免疫學學會 (AAAAI) 發布的估計，過敏性鼻炎影響著全球約 10% 至 30% 的人口，並影響著全世界過敏藥物的採用。

技術先進產品的日益整合，包括使用人工智慧技術來改善治療結果和疾病管理，正在幫助從業者的決策流程。此外，擴大採用行動醫療應用程式來診斷鼻炎等過敏症，預計也將提振市場。例如，MASK-Air 應用程式專門針對過敏性鼻炎。

由於單株抗體具有高效、長期耐受性和安全性，預計將有助於開發解決特定過敏問題的新治療方法。因此，各大公司正在開發針對選擇性標靶的標靶特異性機制設計的新型有效的生物製藥，尤其是單株抗體。此外，針對過敏性疾病的非常重要的單株抗體的一致產品核可預計將擴大成長範圍。

抗免疫球蛋白 E (IgE) 抗體、細胞激素調節劑和 DNA 疫苗接種等新治療方法正在用於治療過敏性疾病。Omalizumab是一種重組人源化 IgG1 單株抗 IgE 抗體，用於治療慢性過敏性蕁麻疹和氣喘。 2021年4月，基因泰克（羅氏集團）宣布其自行注射注射注射器Xolair（ Omalizumab）在美國獲得FDA核准，用於治療慢性特發性氣喘、過敏性氣喘和鼻息肉。

過敏診斷和治療藥物市場競爭適中，默克公司、賽默飛世爾科技公司、雅培公司和輝瑞公司等知名公司擁有強大的影響力。這些公司正在採取各種措施來提高能力、擴大產品系列併提高能力。

過敏診斷和治療藥物市場報告亮點

  • 2022年，消耗品領域在過敏診斷和治療藥物市場中佔據最大佔有率。 MeDALL 過敏原晶片等產品的推出可提高靈敏度、準確性和檢測速度，預計將推動市場成長。
  • 由於治療選擇的增加和患者對藥物過敏意識的提高，藥物過敏領域預計將出現高速成長。
  • 由於氣喘、鼻炎、過敏性結膜炎等過敏症發生率不斷上升，以及全球過敏檢測需求增加，2022年試管內檢測佔比最高。
  • 2022 年，腎上腺素在藥物類別中占主導地位。主要企業推出具有成本效益的腎上腺素注射器預計將顯著促進市場成長。
  • 由於人們越來越了解過敏治療藥物的巨大潛力，2022 年過敏診斷和治療藥物市場將由北美主導。這導致美國公司大力投資開發這些藥物。
  • 預計亞太地區未來幾年將出現顯著成長，特別是由於氣喘、慢性咳嗽和食物過敏的盛行率不斷上升。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系
  • 過敏診斷與治療藥物市場 - 市場動態
  • 商業環境工具分析：過敏診斷與治療藥物市場
  • 管道分析

第4章過敏診斷和治療藥物市場：類型估計和趨勢分析

  • 按類型分類的過敏診斷和治療藥物市場：要點
  • 過敏診斷和治療藥物市場：2023年和2030年類型趨勢和市場佔有率分析
  • 診斷
  • 治療藥物

第5章過敏診療藥物市場：過敏原類型估算及趨勢分析

  • 過敏診斷和治療藥物市場（按過敏原類型）：重點
  • 過敏診斷和治療藥物市場：2023年和2030年過敏原類型趨勢和市場佔有率分析
  • 食品
  • 吸入
  • 藥品
  • 其他過敏原類型

第6章 過敏診斷市場：測試類型估算及趨勢分析

  • 按測試類型分類的過敏診斷市場：重點
  • 過敏診斷市場：2023年和2030年測試類型趨勢和市場佔有率分析
  • 體內測試
  • 體外測試

第7章 過敏診斷與治療藥物市場：區域估算與趨勢分析

  • 過敏診斷與治療藥物市場：2023年及2030年區域變化分析
  • 北美洲
    • 2018-2030年北美過敏診斷和治療藥物市場估計和預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030年歐洲過敏診斷與治療藥物市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太地區過敏診斷與治療藥物市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2018-2030年拉丁美洲過敏診斷與治療藥物市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 2018-2030年中東和非洲過敏診斷和治療藥物市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭形勢

  • 公司分類
  • 2023 年公司市場佔有率分析
  • 策略規劃
  • 公司簡介/名單
    • R-Biopharm AG
    • EUROIMMUN Medizinische Labordiagnostika AG
    • DASIT Group SPA
    • AESKU.GROUP GmbH
    • bioMerieux
    • Danaher
    • Thermo Fisher Scientific, Inc
    • Stallergenes Greer
    • Minaris Medical America, Inc.
    • Siemens Healthcare GmbH
    • Omega Diagnostics Group PLC
    • HYCOR Biomedical
    • Lincoln Diagnostics, Inc.
    • Alcon
    • HOB Biotech Group Corp., Ltd.
    • AbbVie Inc.
    • Allergy Therapeutics
    • Sanofi
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • GSK plc
    • F. Hoffmann-La Roche Ltd.
    • Merck &Co., Inc.
    • Astellas Pharma Inc.
Product Code: 978-1-68038-701-8

Allergy Diagnostics And Therapuetics Market Growth & Trends:

The global allergy diagnostics and therapeutics market size was estimated at USD 58.31 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing incidences of allergic diseases, coupled with demand for advanced therapeutics, is expected to drive the market growth in the coming years. According to estimates published by the American Academy of Allergy Asthma & Immunology (AAAAI), allergic rhinitis affects approximately 10-30% of the global population, thereby impacting the adoption of allergy therapeutics globally.

The increasing integration of technologically advanced products, such as the use of artificial intelligence technology to advance treatment outcomes and manage diseases, helps practitioners in the decision-making process. Furthermore, the rising adoption of mHealth apps for diagnosing allergies such as rhinitis is expected to boost the market. For instance, the MASK-Air app is dedicated specifically to allergic rhinitis.

Monoclonal antibodies are anticipated to contribute to the development of new therapies that eradicate specific allergy concerns, owing to their higher efficacy, long-term tolerability, and safety. Hence, key companies are developing novel & effective biologic-based therapies designed with target-specific mechanisms directed toward selective targets, especially monoclonal antibodies. In addition, consistent product approvals of highly significant monoclonal antibodies for allergy disorders are anticipated to expand the scope for growth.

New therapies such as anti-immunoglobulin E (IgE) antibodies, cytokine modulators, and DNA vaccinations are being used to treat allergic disorders. Omalizumab is a recombinant humanized IgG1 monoclonal anti-IgE antibody, which is used for treating allergic chronic urticaria and asthma. In April 2021, Genentech (Roche Group) announced that its prefilled syringe for self-injection has received FDA approval for Xolair (omalizumab) in the U.S. for chronic idiopathic urticaria allergic asthma, and nasal polyps.

The allergy diagnostics & therapeutics market is moderately competitive, with a strong presence of notable companies such as Merck & Co., Inc, Thermo Fisher Scientific, Inc., Abbott, and Pfizer, Inc. These players are undertaking various initiatives to increase their capabilities, expand their product portfolios, and improve their competencies.

Allergy Diagnostics And Therapuetics Market Report Highlights:

  • The consumables product segment held the largest share in the allergy diagnostics & therapeutics market in 2022. The advent of products that include the MeDALL allergen-chip, which is linked with increased sensitivity, precision, and faster detection, is anticipated to encourage market growth
  • The drug allergies segment is expected to advance lucratively due to the increasing availability of treatment options and growing awareness about drug allergies among patients
  • In vitro tests accounted for the highest share in 2022 due to an increase in the incidence of allergies such as asthma, rhinitis, & allergic conjunctivitis, and a rise in demand for allergy testing globally
  • Epinephrine dominated the drug class segment in 2022. The introduction of cost-effective epinephrine autoinjectors by key companies is expected to significantly augment market growth
  • North America dominated the allergy diagnostics & therapeutics market in 2022, due to an increase in understanding of the high potential associated with allergy drugs. This has driven U.S.-based firms to make considerable investments in the development of these drugs
  • Asia Pacific is expected to witness considerable growth in the future owing to the rising incidences of asthma, chronic cough, and food allergies, among others, in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
    • 1.5.1. Commodity Flow Analysis
      • 1.5.1.1. Approach 1: Commodity flow approach
      • 1.5.1.2. Approach 2: Country-wise market estimation using bottom-up approach
  • 1.6. Data Validation & Publishing
  • 1.7. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

  • 3.1. Market Lineage
    • 3.1.1. Parent Market Analysis
    • 3.1.2. Ancillary Market Analysis
  • 3.2. Allergy Diagnostics & Therapeutics Market - Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising incidence of allergies
      • 3.2.1.2. Advancements in technology and launch of new products
      • 3.2.1.3. High adoption of immunotherapy drugs
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Low adoption and penetration in developing countries due to the high cost of technology
      • 3.2.2.2. Lack of allergen standardization
  • 3.3. Business Environmental Tools Analysis: Allergy Diagnostics & Therapeutics Market
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTLE Analysis
  • 3.4. Pipeline Analysis

Chapter 4. Allergy Diagnostics & Therapeutics Market: Type Estimates & Trend Analysis

  • 4.1. Allergy Diagnostics & Therapeutics Market, By Type: Key Takeaways
  • 4.2. Allergy Diagnostics & Therapeutics Market: Type Movement & Market Share Analysis, 2023 & 2030
  • 4.3. Diagnostics
    • 4.3.1. Global Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Instruments
      • 4.3.2.1. Global Instruments Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Consumables
      • 4.3.3.1. Global Consumables Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Services
      • 4.3.4.1. Global Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Therapeutics
    • 4.4.1. Global Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Antihistamines
      • 4.4.2.1. Global Antihistamines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Decongestants
      • 4.4.3.1. Global Decongestants Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Corticosteroids
      • 4.4.4.1. Global Corticosteroids Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Mast Cell Stabilizers
      • 4.4.5.1. Global Mast Cell Stabilizers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Leukotriene Inhibitors
      • 4.4.6.1. Global Leukotriene Inhibitors Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.7. Nasal Anti-cholinergic
      • 4.4.7.1. Global Nasal Anti-cholinergic Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.8. Immuno-modulators
      • 4.4.8.1. Global Immuno-modulators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.9. Epinephrine
      • 4.4.9.1. Global Epinephrine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.10. Immunotherapy
      • 4.4.10.1. Global Immunotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Allergy Diagnostics & Therapeutics Market: Allergen Type Estimates & Trend Analysis

  • 5.1. Allergy Diagnostics & Therapeutics Market, By Allergen type: Key Takeaways
  • 5.2. Allergy Diagnostics & Therapeutics Market: Allergen type Movement & Market Share Analysis, 2023 & 2030
  • 5.3. Food
    • 5.3.1. Global Food Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Dairy Products
      • 5.3.2.1. Global Dairy Products Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Poultry Product
      • 5.3.3.1. Global Poultry Products Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Tree Nuts
      • 5.3.4.1. Global Tree Nuts Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Peanuts
      • 5.3.5.1. Global Peanut Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.6. Shellfish
      • 5.3.6.1. Global Shellfish Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. Wheat
      • 5.3.7.1. Global Wheat Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.8. Soy
      • 5.3.8.1. Global Soy Allergy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.9. Other Food Allergens
      • 5.3.9.1. Global Food Allergens Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Inhaled
    • 5.4.1. Global Inhaled Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Drug
    • 5.5.1. Global Drug Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others allergen types
    • 5.6.1. Global Other allergen types Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Allergy Diagnostics Market: Test Type Estimates & Trend Analysis

  • 6.1. Allergy Diagnostics Market, By Test Type: Key Takeaways
  • 6.2. Allergy Diagnostics Market: Test Type Movement & Market Share Analysis, 2023 & 2030
  • 6.3. In Vivo tests
    • 6.3.1. Global In Vivo tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Skin Prick Test
      • 6.3.2.1. Global Skin Prick Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Intradermal Test
      • 6.3.3.1. Global Intradermal Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Patch Test
      • 6.3.4.1. Global Patch Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4. In Vitro tests
    • 6.4.1. Global In Vitro tests Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Allergy Diagnostics & Therapeutics Market: Regional Estimates & Trend Analysis

  • 7.1. Allergy Diagnostics & Therapeutics Market: Regional Movement Analysis, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Prevalence Insights
      • 7.2.2.4. Regulatory Framework
      • 7.2.2.5. Reimbursement Structure
      • 7.2.2.6. U.S. Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Prevalence Insights
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Structure
      • 7.2.3.6. Canada Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Prevalence Insights
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. Reimbursement Structure
      • 7.3.2.6. UK Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Prevalence Insights
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Structure
      • 7.3.3.6. Germany Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Prevalence Insights
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Structure
      • 7.3.4.6. France Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Prevalence Insights
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Structure
      • 7.3.5.6. Italy Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Prevalence Insights
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Structure
      • 7.3.6.6. Spain Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Prevalence Insights
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Structure
      • 7.3.7.6. Denmark Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Prevalence Insights
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Structure
      • 7.3.8.6. Sweden Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Prevalence Insights
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Structure
      • 7.3.9.6. Norway Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Prevalence Insights
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Reimbursement Structure
      • 7.4.2.6. Japan Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Prevalence Insights
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Structure
      • 7.4.3.6. China Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Prevalence Insights
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Structure
      • 7.4.4.6. India Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Prevalence Insights
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Structure
      • 7.4.5.6. Australia Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Prevalence Insights
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Structure
      • 7.4.6.6. Thailand Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Prevalence Insights
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Structure
      • 7.4.7.6. South Korea Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Prevalence Insights
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Reimbursement Structure
      • 7.5.2.6. Brazil Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Prevalence Insights
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Structure
      • 7.5.3.6. Mexico Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Prevalence Insights
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Reimbursement Structure
      • 7.5.4.6. Argentina Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. Middle East & Africa Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Prevalence Insights
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. Reimbursement Structure
      • 7.6.2.6. South Africa Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Prevalence Insights
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Structure
      • 7.6.3.6. Saudi Arabia Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Prevalence Insights
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Structure
      • 7.6.4.6. UAE Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Prevalence Insights
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Structure
      • 7.6.5.6. Kuwait Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Company Market Share Analysis, 2023
  • 8.3. Strategy Mapping
  • 8.4. Company Profiles/Listing
    • 8.4.1. R-Biopharm AG
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. EUROIMMUN Medizinische Labordiagnostika AG
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. DASIT Group SPA
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. AESKU.GROUP GmbH
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. bioMerieux
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Danaher
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Thermo Fisher Scientific, Inc
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Stallergenes Greer
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Minaris Medical America, Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Siemens Healthcare GmbH
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Omega Diagnostics Group PLC
      • 8.4.11.1. Overview
      • 8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives
    • 8.4.12. HYCOR Biomedical
      • 8.4.12.1. Overview
      • 8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Strategic Initiatives
    • 8.4.13. Lincoln Diagnostics, Inc.
      • 8.4.13.1. Overview
      • 8.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.13.3. Product Benchmarking
      • 8.4.13.4. Strategic Initiatives
    • 8.4.14. Alcon
      • 8.4.14.1. Overview
      • 8.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.14.3. Product Benchmarking
      • 8.4.14.4. Strategic Initiatives
    • 8.4.15. HOB Biotech Group Corp., Ltd.
      • 8.4.15.1. Overview
      • 8.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.15.3. Product Benchmarking
      • 8.4.15.4. Strategic Initiatives
    • 8.4.16. AbbVie Inc.
      • 8.4.16.1. Overview
      • 8.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.16.3. Product Benchmarking
      • 8.4.16.4. Strategic Initiatives
    • 8.4.17. Allergy Therapeutics
      • 8.4.17.1. Overview
      • 8.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.17.3. Product Benchmarking
      • 8.4.17.4. Strategic Initiatives
    • 8.4.18. Sanofi
      • 8.4.18.1. Overview
      • 8.4.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.18.3. Product Benchmarking
      • 8.4.18.4. Strategic Initiatives
    • 8.4.19. Pfizer Inc.
      • 8.4.19.1. Overview
      • 8.4.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.19.3. Product Benchmarking
      • 8.4.19.4. Strategic Initiatives
    • 8.4.20. Teva Pharmaceutical Industries Ltd.
      • 8.4.20.1. Overview
      • 8.4.20.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.20.3. Product Benchmarking
      • 8.4.20.4. Strategic Initiatives
    • 8.4.21. Sun Pharmaceutical Industries Ltd.
      • 8.4.21.1. Overview
      • 8.4.21.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.21.3. Product Benchmarking
      • 8.4.21.4. Strategic Initiatives
    • 8.4.22. GSK plc
      • 8.4.22.1. Overview
      • 8.4.22.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.22.3. Product Benchmarking
      • 8.4.22.4. Strategic Initiatives
    • 8.4.23. F. Hoffmann-La Roche Ltd.
      • 8.4.23.1. Overview
      • 8.4.23.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.23.3. Product Benchmarking
      • 8.4.23.4. Strategic Initiatives
    • 8.4.24. Merck & Co., Inc.
      • 8.4.24.1. Overview
      • 8.4.24.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.24.3. Product Benchmarking
      • 8.4.24.4. Strategic Initiatives
    • 8.4.25. Astellas Pharma Inc.
      • 8.4.25.1. Overview
      • 8.4.25.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.25.3. Product Benchmarking
      • 8.4.25.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Allergy Diagnostics & Therapeutics Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 Global Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 6 Global Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 7 Global Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 8 North America Allergy Diagnostics & Therapeutics Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 11 North America Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 12 North America Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 17 Canada Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 19 Canada Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 20 Canada Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 21 Europe Allergy Diagnostics & Therapeutics Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 24 Europe Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 25 Europe Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 26 UK Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 UK Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 28 UK Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 29 UK Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 30 Germany Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 31 Germany Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 32 Germany Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 33 Germany Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 34 France Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 France Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 36 France Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 37 France Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 38 Italy Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 40 Italy Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 41 Italy Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 42 Spain Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 Spain Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 44 Spain Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 45 Spain Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 46 Denmark Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Denmark Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 48 Denmark Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 49 Denmark Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 50 Sweden Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Sweden Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 52 Sweden Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 53 Sweden Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 54 Norway Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 Norway Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 56 Norway Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 57 Norway Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Allergy Diagnostics & Therapeutics Market, By Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 63 Japan Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 64 Japan Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 65 Japan Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 66 Japan Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 67 China Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 China Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 69 China Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 70 China Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 71 India Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 72 India Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 73 India Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 74 India Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 75 Australia Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 Australia Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 77 Australia Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 78 Australia Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 79 South Korea Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 80 South Korea Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 81 South Korea Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 82 South Korea Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 83 Thailand Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 84 Thailand Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 85 Thailand Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 86 Thailand Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 87 Latin America Allergy Diagnostics & Therapeutics Market, By Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Latin America Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 90 Latin America Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 91 Latin America Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 92 Brazil Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 93 Brazil Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 94 Brazil Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 95 Brazil Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 96 Mexico Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 97 Mexico Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 98 Mexico Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 99 Mexico Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 100 Argentina Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 101 Argentina Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 102 Argentina Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 103 Argentina Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 104 MEA Allergy Diagnostics & Therapeutics Market, By Country, 2018 - 2030 (USD Million)
  • Table 105 MEA Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 106 MEA Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 107 MEA Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 108 MEA Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 109 South Africa Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 110 South Africa Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 111 South Africa Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 112 South Africa Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 117 UAE Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 118 UAE Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 119 UAE Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 120 UAE Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Allergy Diagnostics & Therapeutics Market, By Type, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Allergy Diagnostics & Therapeutics Market, By Test Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Allergy Diagnostics & Therapeutics Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment.
  • Fig. 8 Market formulation & validation
  • Fig. 9 Allergy Diagnostics & Therapeutics Market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Allergy Diagnostics & Therapeutics Market driver impact
  • Fig. 14 Allergy Diagnostics & Therapeutics Market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Allergy Diagnostics & Therapeutics Market: Type outlook and key takeaways
  • Fig. 19 Allergy Diagnostics & Therapeutics Market: Type movement analysis & market share 2023 & 2030
  • Fig. 20 Diagnostics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Consumable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Antihistamines Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Angiotensin 2 Receptor Blockers Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Decongestants Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Corticosteroids Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Mast Cell Stabilizers Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Leukotriene Inhibitors Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Nasal Anti-cholinergic Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Immuno-modulators Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Epinephrine Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Immunotherapy Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Allergy Diagnostics & Therapeutics Market: Allergen Type outlook and key takeaways
  • Fig. 36 Allergy Diagnostics & Therapeutics Market: Allergen Type movement analysis & market share 2023 & 2030
  • Fig. 37 Food market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Dairy Products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Poultry Product market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Tree Nuts market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Peanuts market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Shellfish market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Wheat market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Soy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Other Food Allergens market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Inhaled market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Drug market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Allergy Diagnostics & Therapeutics Market: Test Type outlook and key takeaways
  • Fig. 50 Allergy Diagnostics & Therapeutics Market: Test Type movement analysis & market share 2023 & 2030
  • Fig. 51 In vivo Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Skin Prick Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Intradermal Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Patch Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 In Vitro Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Allergy Diagnostics & Therapeutics Market: Regional outlook and key takeaways
  • Fig. 57 Regional outlook, 2023 & 2030
  • Fig. 58 North America
  • Fig. 59 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 U.S. key country dynamics
  • Fig. 61 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Canada key country dynamics
  • Fig. 63 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Europe
  • Fig. 65 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 UK key country dynamics
  • Fig. 67 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Germany
  • Fig. 69 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 France key country dynamics
  • Fig. 71 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Italy key country dynamics
  • Fig. 73 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Spain key country dynamics
  • Fig. 75 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Denmark key country dynamics
  • Fig. 77 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Sweden key country dynamics
  • Fig. 79 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Norway key country dynamics
  • Fig. 81 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Asia-Pacific
  • Fig. 83 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Japan key country dynamics
  • Fig. 85 Japan market estimates and forecast, 2018 - 2030(USD Million)
  • Fig. 86 China key country dynamics
  • Fig. 87 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 India key country dynamics
  • Fig. 89 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 South Korea key country dynamics
  • Fig. 91 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Australia key country dynamics
  • Fig. 93 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Thailand key country dynamics
  • Fig. 95 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Latin America
  • Fig. 97 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Brazil key country dynamics
  • Fig. 99 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Mexico key country dynamics
  • Fig. 101 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Argentina key country dynamics
  • Fig. 103 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 Middle East & Africa
  • Fig. 105 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 106 South Africa key country dynamics
  • Fig. 107 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 108 Saudi Arabia key country dynamics
  • Fig. 109 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 110 UAE key country dynamics
  • Fig. 111 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 112 Kuwait key country dynamics
  • Fig. 113 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 114 Market differentiators
  • Fig. 115 Key company market share analysis, 2023